Orient New Life Medical Co.,Ltd.


Quality is life.


About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Company News
Home ProductsElisa Test Kit

Medical Elisa Test Kit CE , Toxo IgG Rapid Elisa Test Quantitative Determination

I'm Online Chat Now
China Orient New Life Medical Co.,Ltd. certification
China Orient New Life Medical Co.,Ltd. certification
We are satisfied with your quality & services so far. The HIV 1/2 antibody Test performance is perfect.

—— Katrina

I have to say that New Life provides high quality products. The FOB, Troponin I, HIV, HCV, Drug Abuse test all performed very well in our market.

—— Clemen

Your Dengue IgG/IgM and Malaria test perfromed well. Now we want to try your Filariasis test in our market.

—— Primo

Medical Elisa Test Kit CE , Toxo IgG Rapid Elisa Test Quantitative Determination

Medical Elisa Test Kit CE , Toxo IgG Rapid Elisa Test Quantitative Determination
Medical Elisa Test Kit CE , Toxo IgG Rapid Elisa Test Quantitative Determination

Large Image :  Medical Elisa Test Kit CE , Toxo IgG Rapid Elisa Test Quantitative Determination Get Best Price

Product Details:
Place of Origin: China
Brand Name: New Life
Certification: ISO, CE
Model Number: 96 wells
Payment & Shipping Terms:
Minimum Order Quantity: 10 kit
Packaging Details: 96T/kit
Delivery Time: 20-35days
Payment Terms: T/T, Western Union
Supply Ability: 100000kit/month
Detailed Product Description
Category: Elisa Test Kit Format: 96T/KIT
Valid: 24 Month Accuracy: 99.95%
Sensitivity: 99.94% Application: Toxo IgG
High Light:

elisa diagnostic kits


rapid elisa test

Toxoplasma gondii (Toxo) IgG ELISA test, high accuracy, Elisa Sandwich method, for quantitative measurement



Product Name:  Toxoplasma gondii (Toxo) IgG ELISA test



Intended Use:


Toxoplasma gondii (Toxo) IgG Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to Toxoplasma gondii in human sera. This product is not FDA cleared (approved) for use in testing (ie, screening) blood or plasma donors. For in vitro diagnostic Use. High complexity test.




Toxoplasma gondii causes toxoplasmosis, a common disease that affects 30-50 of every 100 people in North America by the time they are adults. The mean source of infection is direct contact with cat feces or from eating undercooked meats. Toxoplasmosis generally presents with mild symptoms in immunocompetent individuals; in the immunocompromised patient, however, the infection can have serious consequences. Acute toxoplasmosis in pregnant women can result in result in miscarriage, poor growth, early delivery or stillbirth. Treatment of an infected pregnant woman may prevent or lessen the disease in her unborn child. Treatment of an infected infant will also lessen the severity of the disease as the child grows. IgG and IgM antibodies to Toxoplasma can be detected with 2-3 weeks after exposure. IgG remains positive, but the antibody level drops overtime. ELISA can detect Toxoplasma IgM antibody after one year after infection in over 50% of patients. Therefore, IgM positive results should be evaluated further with one or two follow up samples if primary infection is suspected.


Principle of Test:


Toxoplasma gondii IgG ELISA Kit is a solid-phase immunoanalytical test. The purified, homogeneous antigen

is fixed to each well of the microtiterstrips. Specific antibodies present in the patient’s sample are bound during

the first incubation step. After removing unbound material by washing, the presence of the specific antibodies

is detected using anti-human IgG conjugate during the second incubation. The unbound peroxidase conjugate

is then removed and TMB substrate is added, resulting in the development of a blue colour. The enzyme

reaction is terminated by addition of the stop solution. The intensity of the colour is proportional to the

concentration of the antibodies in the sample.



Kit Components


Component Amount
ELISA break-away strips coated with the specific antigen 96 wells
Negative control r.t.u. 1) 1.2 mL 1 vial
Calibrator 1 r.t.u., 10 IU 2) 1.2 mL 1 vial
Calibrator 2 r.t.u., 50 IU 1.2 mL 1 vial
Calibrator 3 r.t.u., 100 IU 1.2 mL 1 vial
Calibrator 4 r.t.u., 200 IU 1.2 mL 1 vial
Peroxidase conjugate (anti-IgG/Px) r.t.u. 12 mL 1 vial
Wash buffer 25x concentrated 80 mL 1 vial
Dilution buffer r.t.u. 100 mL 1 vial
Chromogenic substrate TMB r.t.u. 13 mL 1 vial
Stop solution, r.t.u. 15 mL 1 vial
Cover membrane 3 piece
Bag with zipper + desiccant 1
1) r.t.u., ready to use  
2) IU, International Units  








  1.  Allow the vacuum-closed aluminium bag with strips to reach room temperature. Withdraw an adequate number of strips and put the unused strips into the provided bag and seal it carefully with the desiccant kept inside.
  2.  Pipette 100 µL of Sample diluent, Controls and serum samples to the wells according to the pipetting scheme in Plate Layout: fill the first well with Dilution buffer (DIL) to determine the reaction background. Fill the next two wells with Calibrator 1 (CAL 1). The next wells fill with Calibrator 2-4 (CAL 2-4) and Negative control (CONTROL 1). The remaining wells fill with diluted serum samples (S1...). It is satisfactory to apply one serum into one well (S1, S2, S3...). However, if you want to minimize a laboratory error, apply controls and samples as doublets. Cover the strips with the Cover membrane or cover.
  3.  Incubate 60 minutes (+/- 5 min.) at 37°C in a humid chamber.
  4.  Aspirate the liquid from wells into a collecting bottle containing appropriate disinfectant (see Safety Precautions). Wash and aspirate the wells four times with 300 µl/well of Wash buffer. Avoid cross-contamination between wells! If some liquid remains in the wells, invert the plate and tap it on an adsorbent paper to remove the last remaining drops.
  5.  Add 100 µL Peroxidase conjugate r.t.u. into each well. Incubate 30 minutes (+/- 2 min) at 37°C in a humid chamber.
  6.   Aspirate and wash four times with 300 µl/well of Wash buffer.
  7.  Dispense 100 µl of TMB into each well. Incubate 15 minutes (+/- 30 seconds) at room temperature. The time measurement must be started at the beginning of TMB dispensing. Cover the strips with opaque cover or keep them in the dark during the incubation with TMB.
  8.  Stop the reaction by adding 100 µL of Stop solution. Use the same pipetting rhythm as with the TMB to ensure the same reaction time in all wells. Tap gently the microplate for a few times to ensure complete mixing of the reagents.
  9.  Read the absorbance at 450 nm with a microplate reader within 10 minutes. It is recommended to use a reference reading at 630 (620) nm.


Contact: Jerry Meng
Email: Jerry @ newlifebiotest .com
Tel. +86 18657312116
SKYPE enetjerry

Contact Details
Orient New Life Medical Co.,Ltd.

Contact Person: Jerry Meng

Tel: +8618657312116

Send your inquiry directly to us